Navigation Links
MedReps.com Survey Reveals Best Places to Work in Medical Sales in 2014
Date:1/14/2014

Alpharetta, GA (PRWEB) January 14, 2014

A new survey by MedReps.com (http://www.medreps.com/), a job board for medical sales representatives, revealed that Medtronic is once again the overall best medical sales company for which to work, as voted by more than 1,000 members of the MedReps.com community. Also at the top of the list were Stryker and Boston Scientific. The 2014 Best Places to Work in Medical Sales Survey provided insight into additional aspects of medical sales companies that are most valued by sales representatives, including size, type of sales, competitive compensation, and commitment to research and development.

“It isn’t just medical sales companies that can benefit from the data found in this survey,” said Robyn Melhuish, Communications Manager at MedReps.com. “Job seekers can also gain a better understanding of what companies align with what they value most and pursue a more targeted search.”

Notable findings from the survey include the following:

  • Medtronic was ranked as the overall best medical sales companies for which to work, with Stryker and Boston Scientific ranked as second and third, respectively.
  • While those that were ranked highest are all large companies, more than half of respondents said they’d ideally like to work for a medium-sized company (48 percent) or a small company (11 percent).
  • More than half (53 percent) of all respondents prefer to sell medical devices or medical equipment.
  • Survey respondents overwhelmingly ranked competitive compensation and commission structure as the most important benefit offered by a prospective employer; work-life balance was a close second.
  • The medical sales professionals surveyed highly value a company committed to research and development.
  • When it comes to evaluating prospective employers, medical sales professionals want to know the company has a strong product line. In this fast paced, ever-changing industry, sales representatives desire a company committed to research and development that will continue to offer quality products in the future.

“With this data, we hope to help job seekers find the best opportunities available,” Melhuish said. “But they must also remain flexible. Not every job seeker will be hired by the top ranked companies, but there are thousands of other growing healthcare companies willing to pay for top talent.”

This survey analyzed data collected from more than 1,000 professionals currently working in medical sales. To access more information from this survey, click here.

About MedReps.com
MedReps.com is owned and operated by Healthcare Staffing Technologies. As the leading job site in its niche, MedReps.com gives members access to the most sought after medical sales jobs and pharmaceutical sales jobs on the web. Members have access to approximately 9,000 jobs and can apply directly to the recruiters and hiring managers who post them. For more information on the No. 1 site for medical sales, marketing, and management careers, please visit MedReps.com.

###

Read the full story at http://www.prweb.com/releases/2014/01/prweb11460748.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. MedReps.com Report Shows Biotech Workers Earn the Most in Medical Sales
2. New Survey Suggests Priobiotics Could be the Key to Encouraging More Patients to Complete a Course of Antibiotics
3. Anterios, Inc., Announces Results of Consumer Survey Revealing Widespread Problem of Excessive Sweating and Desire for New Topical Botulinum Toxin Treatment
4. International Survey Finds Self-Administered Treatment on the Rise Among Hereditary Angioedema Patients
5. TrialNetworks Feasibility Survey™ App Gets ARIAD Pharmaceuticals Unprecedented 75% Response from Potential Clinical Trial Investigator Sites
6. Photonics Pros Love Their Work, New SPIE Survey Shows
7. Surveyed U.S. Payers Are Significantly More Likely To Reimburse Biosimilars Developed By Multinational Manufacturers Compared With Those Developed By Regional Emerging Market Players
8. Veeva CRM Adds New Survey Functionality to Deepen Customer Understanding and Drive More Relevant Interactions
9. Surveyed Physicians Indicate that Xtandi is Prescribed to Nearly One Quarter of Metastatic Castrate-Resistant Prostate Cancer Patients Who Have Failed to Respond to Prior Docetaxel Treatment
10. At Three Months Post Launch, Two-Thirds of Surveyed U.S. Rheumatologists Believe that Initiations of Pfizers Xeljanz in the Rheumatoid Arthritis Treatment Algorithm Will Occur Following at Least Two Biologic Failures
11. Honey Bee Winter Loss Survey Results to Date: Losses of 40 to 50%, Twice the Average in 2011
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/9/2016)... BERG, a biopharmaceutical company uncovering health ... announced the appointment of Jason Haddock ... Haddock brings to BERG over 20 years of ... senior financial functions at pharmaceutical companies, as well ... Niven R. Narain , BERG,s ...
(Date:2/8/2016)... Feb. 8, 2016 /PRNewswire/ - BIOREM Inc. (TSXV: BRM) ("Biorem" ... ten finalists for clean technology companies in the TSX Venture ... 10 companies listed on the TSX Venture Exchange, in each ... clean technology & life sciences, diversified industries and ... given to return on investment, market cap growth, trading volume ...
(Date:2/8/2016)... 2016  CytRx Corporation (NASDAQ: CYTR ), ... oncology, today announced that it has entered into ... Technology Growth Capital, Inc. and Hercules Technology III, ... --> --> ... financing under the loan and security agreement.  The ...
(Date:2/8/2016)... -- Novan, Inc. today announced that Director Robert A. Ingram ... Novan. In addition, Robert Keegan has been appointed to ... . --> North Carolina . ... total of $32.8 million of net proceeds in a private Mezzanine ... throughout the Research Triangle area of North Carolina ...
Breaking Biology Technology:
(Date:2/3/2016)... 2016 --> ... "Automated Fingerprint Identification System Market by Component (Hardware and ... & Finance, Government, Healthcare, and Transportation) and Geography - ... is expected to be worth USD 8.49 Billion by ... and 2020. The transformation and technology evolution from the ...
(Date:2/2/2016)... 2016 Checkpoint Inhibitors for Cancer – ... Are you interested in the future of cancer ... inhibitors. Visiongain,s report gives those predictions to 2026 ... level. Avoid falling behind in data or ... revenues those emerging cancer therapies can achieve. There ...
(Date:2/1/2016)... 2016  Today, the first day of American Heart ... develop a first of its kind workplace health solution ... In the first application of Watson ... ), and Welltok will create a new offering that ... analytics, delivered on Welltok,s health optimization platform. The effort ...
Breaking Biology News(10 mins):